Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: 1 hour ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR7482Referred to Committee

LymeX Authorization Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-02-11
Introduced
3
Cosponsors
HR
ⓘ
Type

Sponsor

Christopher H. Smith
Christopher H. Smith
Republican · NJ · Representative
Votes with party: 96.0% (602 recorded votes)

Full profile: /officials/S000522

Source: Congress.gov · FEC

Cosponsors (3)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • Lloyd Doggett (D-TX-37)Original· 2026-02-11
  • Josh Gottheimer (D-NJ-5)· 2026-02-23
  • Seth Magaziner (D-RI-2)· 2026-04-13

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2026-02-11

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on Energy and CommerceReferred To · 2026-02-11

Previously

  • Energy and Commerce CommitteeReferred To · 2026-02-11

Plain-English Summary

This bill would authorize funding and support for research, prevention, and treatment programs related to Lyme disease, a tick-borne illness that affects thousands of Americans each year. The legislation aims to improve how the disease is diagnosed, managed, and studied, potentially benefiting patients dealing with Lyme disease as well as public health agencies working to reduce infections. The bill is currently under review by the House Committee on Energy and Commerce.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HR5160Stem Cell Therapeutic and Research Reauthorization Act of 2025
    Referred to Committee · 2026-07-02
  • HR4348To reauthorize the Kay Hagan Tick Act, and for other purposes.
    Reported by Committee · 2026-07-02
  • HRES1400Condemning the People's Republic of China's Law on the Promotion of Ethnic Unity and Progress and the Chinese Communist Party's campaign of forced assimilation against ethnic and religious minorities.
    Referred to Committee · 2026-06-30
  • HR9531Preventing Stomach Cancer in Our Nation’s Heroes Act
    Referred to Committee · 2026-06-29